A. Tietz et al., EOSINOPHILIA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, European journal of clinical microbiology & infectious diseases, 16(9), 1997, pp. 675-677
The prevalence and significance of peripheral blood eosinophilia in pa
tients infected with the human immunodeficiency virus (HIV) were evalu
ated. Fifteen of 119 consecutive patients had absolute eosinophil coun
ts of > 450/mm(3). During a mean follow-up period of 419 days eosinoph
ilia could be identified as secondary to a parasitic infection in only
one patient. Correlation with disease stage showed a higher rate of a
dvanced disease in patients with absolute eosinophilia. In a multivari
ate regression analysis, only low CD4+ cell counts, not the CDC diseas
e stage or the use of antiretroviral therapy or primary prophylaxis, c
ontributed significantly to the prevalence of eosinophilia. It is conc
luded that expen-sive laboratory investigations in asymptomatic patien
ts with advanced-stage HIV disease are neither necessary nor cost effe
ctive.